Lhasa Limited shared knowledge shared progress

Events

When

24 June 2021

Where

Online

2021 Webinar | Why you should consider controlling your potentially mutagenic impurities outside the lab

WorkshopFree

2021 Webinar | Why you should consider controlling your potentially mutagenic impurities outside the lab

We are delighted to have Andrew Teasdale PhD presenting within this webinar; Why you should consider controlling your potentially mutagenic impurities outside the lab.

Andrew is currently the chair of AstraZeneca’s Impurity Advisory Board and has a wealth of knowledge developed over the last 20 years of working within the pharmaceutical industry. He is a leading AZ expert for a number of key impurity areas, including mutagenic impurities (MIs).

Andrew’s presentation will cover the following topics:

  • The challenges of controlling potentially mutagenic impurities
  • How using the paper-based approach can reduce the time and effort associated with these challenges
  • AstraZeneca’s experience of how Mirabilis can help further
  • Top tips for applying control option 4.

This presentation will be followed by a short Mirabilis software demonstration from Raeesah Saddiq, Lhasa Business Development Executive.

After the presentations we will hold a live Q&A session.

This virtual event will begin at 16:00 (UK time) and will last approximately 90 minutes.

Register to attend here.

  • Headline Event (shown first above featured)

  • Featured Event

Register

Back to events

© 2021 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.